Antiviral agents: clinical status report.
Recently, the clinical focus in antiviral chemotherapy has been on the use of ara-A in herpes infections-HSV encephalitis, zoster in the immunosuppressed, and neonatal herpes. In this last article of a four-part series, the authors review clinical studies that have to date led to the licensing of ara-A for HSV encephalitis but have not yet clearly defined its role in the immunosuppressed or in neonates.
D004660:Encephalitis / Q000175:diagnosis / Q000188:drug therapy*; D006561:Herpes Simplex / Q000175:diagnosis / Q000188:drug therapy*; D006562:Herpes Zoster / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007165:Immunosuppression Therapy; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis / Q000188:drug therapy*; D011379:Prognosis; D014740:Vidarabine / Q000627:therapeutic use*
D014740:Vidarabine